EARLY-STAGE LUNG CANCER
Clinical trials for EARLY-STAGE LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY-STAGE LUNG CANCER trials appear
Sign up with your email to follow new studies for EARLY-STAGE LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill plus chemo aims to stop lung cancer comeback in patients with rare mutations
Disease control OngoingThis phase 3 trial tests whether adding the targeted drug zipalertinib to standard chemotherapy can delay or prevent lung cancer from returning in people with early-stage non-small cell lung cancer (stages IB to IIIA) who have uncommon EGFR mutations. After complete tumor removal…
Matched conditions: EARLY-STAGE LUNG CANCER
Phase: PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
AI eye on lungs: can computers help find hidden cancer?
Knowledge-focused TerminatedThis study planned to see if an artificial intelligence (AI) program called qXR-LN could help radiologists find more lung nodules and cancers on chest X-rays. Researchers would compare how often nodules were detected before and after the AI was put into use. The study was withdra…
Matched conditions: EARLY-STAGE LUNG CANCER
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:03 UTC